Fadi Asfour
No Rating Available
(Learn About Our Rating System)

Fadi Asfour, MD, MBBS

Languages spoken: Arabic, English

Clinical Locations

Primary Location

Eccles Primary Children's Outpatient Services

81 N Mario Capecchi Drive
Salt Lake City , UT 84113
801-213-3599
Get Directions

Dr. Asfour received his Bachelor of Medicine, Bachelor of Surgery degree from Jordan University of Science and Technology. Dr. Asfour completed his pediatric residency at the Women and Children´s Hospital of Buffalo, and his pediatric Pulmonary Fellowship at Children’s Hospital of Los Angeles. Dr. Asfour is board-certified in pediatric pulmonology.

Dr. Asfour is currently a Professor in the Department of Pediatrics at the University of Utah and is in the Division of Pulmonary and Sleep Medicine at Primary Children´s Hospital. Dr. Asfour’s clinical interests include cystic fibrosis, quality improvement, patient experience, team well-being, and global access to care. Dr. Asfour currently serves as the medical director of quality improvement at Primary Children’s Hospital. In November of 2022, Dr. Asfour was named the inaugural holder of the Barbara Chatfield Endowed Chair for cystic fibrosis in the University of Utah.

Specialties

Board Certification

National Board of Medical Examiners
American Board of Pediatrics (Sub: Pediatric Pulmonology)

Dr. Asfour received his Bachelor of Medicine, Bachelor of Surgery degree from Jordan University of Science and Technology. Dr. Asfour completed his pediatric residency at the Women and Children´s Hospital of Buffalo, and his pediatric Pulmonary Fellowship at Children’s Hospital of Los Angeles. Dr. Asfour is board-certified in pediatric pulmonology.

Dr. Asfour is currently a Professor in the Department of Pediatrics at the University of Utah and is in the Division of Pulmonary and Sleep Medicine at Primary Children´s Hospital. Dr. Asfour’s clinical interests include cystic fibrosis, quality improvement, patient experience, team well-being, and global access to care. Dr. Asfour currently serves as the medical director of quality improvement at Primary Children’s Hospital. In November of 2022, Dr. Asfour was named the inaugural holder of the Barbara Chatfield Endowed Chair for cystic fibrosis in the University of Utah.

Board Certification and Academic Information

Academic Departments Pediatrics -Professor (Clinical)
Board Certification
National Board of Medical Examiners
American Board of Pediatrics (Sub: Pediatric Pulmonology)

Education history

Professional Medical Medicine - Jordan University of Science and Technology/King Abdullah University Hospital M.B.B.S.
Internship Al-Basheer Hospital Intern
Internship Internal Medicine/Preliminary - North Side Hospital, Affiliated with North Eastern Ohio Universities Colleges of Medicine Intern
Residency Pediatric - University of Buffalo at The Women and Children¿s Hospital of Buffalo M.D.
Fellowship Pulmonary - University of Southern California at Children¿s Hospital Los Angeles Fellow

Selected Publications

Journal Article

  1. Huang L, Lai HJ, Antos N, Rock MJ, Asfour F, Howenstine M, Gaffin JM, Farrell P (2022). Defining and identifying early-onset lung disease in cystic fibrosis with cumulative clinical characteristics. Pediatric pulmonology,
  2. Rayment JH, Asfour F, Rosenfeld M, Higgins M, Liu L, Mascia M, Paz-Diaz H, Tian S, Zahigian R, McColley SA, VX16-809-122 Study Group (2022). A Phase 3, Open-Label Study of Lumacaftor/Ivacaftor in Children 1 to Less Than 2 Years of Age With Cystic Fibrosis Homozygous for F508del-CFTR. American journal of respiratory and critical care medicine,
  3. Zobell JT, Moss J, Creelman J, Christensen R, Jensen B, Stewart J, Ameel K, Asfour (2023). Implementation of a comprehensive pharmacy-driven immunization care process model in a pediatric cystic fibrosis clinic. Pediatric pulmonology,
  4. Albon D, Thomas L, Hoberg L, Stamper S, Somerville L, Varghese P, Balasa E, Roman M, Britto MT, Miner M, Gehring E, Gammon C, Amin RS, Seid M, Powers M, CF Learning Network telehealth iLab working grou (2022). Cystic fibrosis learning network telehealth innovation lab during the COVID-19 pandemic: a success QI story for interdisciplinary care and agenda setting. BMJ open quality, 11(2),
  5. David P Nichols, Pradeep K Singh, Arthur Baines, Lindsay J Caverly, James F Chmiel, Ronald L GIbson, Jorge Lascano, Sarah J Morgan, George Retsch- Bogart, Lisa Saiman, Hossein Sadeghi, Joanne L Billings, Sonya L Heltshe , Shannon Kirby, Ada Kong, Jerry A Nick, Nicole Mayer- Hamblett, TEACH Study Grou (2021). Testing the effects of combining azithromycin with inhaled tobramycin for P. aeruginosa in cystic fibrosis: a randomised, controlled clinical trial. Thorax,
  6. Yuzyuk T, McDonald CM, Zuromski LM, De Biase I, Johnson L, Williams N, Meihls S, Asfour (2023). Improvement of lipid and lipoprotein profiles in children and adolescents with cystic fibrosis on CFTR modulator therapy. Journal of cystic fibrosis,
  7. Liou TG, Argel N, Asfour F, Brown PS, Chatfield BA, Cox DR, Daines CL, Durham D, Francis JA, Glover B, Helms M, Heynekamp T, Hoidal JR, Jensen JL, Kartsonaki C, Keogh R, Kopecky CM, Lechtzin N, Li Y, Lysinger J, Molina O, Nakamura C, Packer KA, Paine R 3rd, Poch KR, Quittner AL, Radford P, Redway AJ, Sagel SD, Szczesniak RD, Sprandel S, Taylor-Cousar JL, Vroom JB, Yoshikawa R, Clancy JP, Elborn JS, Olivier KN, Adler F (2024). Airway inflammation accelerates pulmonary exacerbations in cystic fibrosis. iScience, 27(3), 108835.
  8. Reed JE, Johnson JK, Zanni R, Messier R, Asfour F, Godfrey M (2024). Quality of locally designed surveys in a quality improvement collaborative: review of survey validity and identification of common errors. BMJ open quality, 13(1),
  9. Blaseg NA, Robson JO, Patel RA, Asfour F, Pohl J (2024). Gastrointestinal Pathologies in Pediatric Patients With Cystic Fibrosis Undergoing Endoscopy: A Single-Center Retrospective Review Over 15 Years. Cureus, 16(4), e59018.
  10. Cathy Liu, Taiya R. Bach, Philip M. Farrell, Derek Pavelec, Nicholas J. Antos, Michael J. Rock, Fadi Asfour, Michelle Howenstine, Jonathan M. Gaffin, HuiChuan J. La (2024). Impact of acid blocker therapy on growth, gut microbiome, and lung disease in young children with cystic fibrosis. Journal of pediatric gastroenterology and nutrition, (2024), 1-10.
  11. Gamel B, Albon D, Bandla S, Davison DW, Flath J, Sabadosa KA, Seid M, Silva L, Ong T, Cystic Fibrosis Learning Network Grou (2024). Interventions to improve system-level coproduction in the Cystic Fibrosis Learning Network. BMJ open quality, 13(3),
  12. Allen S, Vetter M, Davison DW, Cochrane G, Uluer A, Jennings D, Asfour F, Sabadosa KA, Bailey (2024). Cystic Fibrosis Experience of Care Survey: Patient-Caregiver-Clinician Collaborative Design and Implementation. Journal of patient experience, 11, 23743735241302739.
  13. Huang L, Lai HJ, Furuya KN, Antos NJ, Asfour F, Boyne KL, Howenstine M, Rock MJ, Sawicki GS, Gaffin JM, Worthey EA, Farrell P (2025). The Frequency and Potential Implications of HFE Genetic Variants in Children With Cystic Fibrosis. Pediatric pulmonology, 60(3), e71042.
  14. Dana Albon, Thida Ong, Bethany Horton, David Brighton, Shiyi Shen, Rhonda List, Nicholas Antos, Fadi Asfour, Ella Balasa, Danielle Beachler, Cori Daines, Deborah Froh, Catherine Kier, Samya Nasr, Meghana Sathe, Gregory Sawicki, Michael Schechter, George Solomon, Michael Power (2025). Cystic Fibrosis Learning Network Telehealth Innovation Lab During the COVID-19 Pandemic: Impact on Access to Care, Outcomes, and a New CF Care Model. Pediatric pulmonology, 60(5), e71102.

Abstract

  1. Yuzyuk, T.; Balogun, K.; Meihls, S.; Williams, N.; McDonald, K.M.; Asfour, F (2020). Dyslipidemia in Children and Adolescents with Cystic Fibrosis. 55(S2),